Cargando…
A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females
BACKGROUND: Despite the fact that approximately 70% of Canadian women undergo cervical cancer screening at least once every 3 years, approximately 1,300 women were diagnosed with cervical cancer and approximately 380 died from it in 2008. This study estimates the effectiveness and cost-effectiveness...
Autores principales: | Anonychuk, Andrea M, Bauch, Chris T, Merid, Maraki Fikre, Van Kriekinge, Georges, Demarteau, Nadia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777872/ https://www.ncbi.nlm.nih.gov/pubmed/19878578 http://dx.doi.org/10.1186/1471-2458-9-401 |
Ejemplares similares
-
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
por: Li, Xiao, et al.
Publicado: (2015) -
Cost-Utility of a Two-Dose Human Papillomavirus Vaccination Programme Added to Cervical Cancer Screening Compared with Cervical Cancer Screening Alone in Korea
por: Lee, Hyunju, et al.
Publicado: (2019) -
The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review
por: Anonychuk, Andrea, et al.
Publicado: (2013) -
Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada
por: Kohli, Michele, et al.
Publicado: (2012) -
Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2011)